May 02, 2013, 06.26 PM | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Havells India.
Sudarshan Sukhani (more)
Technical Analyst, s2analytics.com | Capital Expertise: Equity - Technical
Sukhani told CNBC-TV18, "The market is up so today there is no need to go and experiment with a short position. We want to buy Havells India. It has moved out of a consolidation. It was already in an uptrend, so the breakout is a continuation of the existing uptrend. Any breakout has some momentum, may be by today 3.30 PM that momentum should give us some points on the long side."
He further added, " Aurobindo Pharma has made a very attractive bullish breakout, it is an ascending triangle. Such breakouts usually tell us that a significant up move is coming, so it is worthwhile getting in today as this move is just beginning to take shape."
Havells India declares special dividend
Havells India Ltd has informed BSE that the Board
Havells launches its first indigenous MCB and RCCB- Euro II series
Havells India today launched its first Made-in-Ind
Havells India may touch Rs 340, says Gaurang Shah
Gaurang Shah of Geojit BNP Paribas Financial Servi
Hold Havells India, may test Rs 380-400: Vishal Malkan
Vishal Malkan of malkansview.com advises holding H
Buy Havells; target of Rs 350:Religare
Religare is bullish on Havells and has recommended
Sell Havells; target of Rs 260:Religare
Religare is bearish on Havells and has recommended
Air pollution kills millions annually, mostly in China, India
According to scientists from the US, Canada, China
Make in India Week: Shiv Sena takes potshots at CM Fadnavis
The Shiv Sena also said that while efforts of the